[
mhra
]
UK regulator approves Covid-19 vaccine from Moderna
By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON JAN 08, 2021 07:42 PM IST
Supplies will begin to be delivered from spring once Moderna expands its production capability, officials said. The vaccine will be available to people for free.

Britain approves use of Covid-19 self-test kit
By Reuters | Posted by Ayshee Bhaduri | London
UPDATED ON DEC 23, 2020 10:55 PM IST
The Medicines and Healthcare products Regulatory Agency said that the kit uses an antigen lateral flow test (antigen LFT), which can give a result in 30 minutes.

MHRA, UK: People with serious allergies must avoid Pfizer vaccine
By Reuters | Posted by Shivani Kale | London
UPDATED ON DEC 09, 2020 06:58 PM IST
UK warns people who with serious allergies with to avoid Pfizer-BioNTech Covid-19 vaccine after two people reported adverse effects on the first day of rollout.

UK looking at allergic reaction to Pfizer-BioNTech vaccine
By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON DEC 09, 2020 05:18 PM IST
“We’re looking at two case reports of allergic reactions,’’said Dr June Raine, head of the UK’s medical regulatory agency as she testified on Wednesday to a Parliamentary committee. “We know from the very extensive clinical trials that this wasn’t a feature.”

How are vaccines approved: All you need to know
By hindustantimes.com | Edited by Srivatsan K C | Hindustan Times, New Delhi
UPDATED ON DEC 03, 2020 06:50 PM IST
With the first bunch of Pfizer vaccines expected to roll out in the UK by next week, as confirmed by Health Secretary Matt Hancock, here is a look at how countries around the world are approving vaccines.

UK first to approve Covid-19 vaccine; roll-out next week
By Prasun Sonwalkar | Hindustan Times, London
UPDATED ON DEC 02, 2020 07:02 PM IST
The Pfizer-BioNTech vaccine with 95% efficacy needs to be initially refrigerated at a temperature of minus 70 to 80 degrees Celsius, and administered in two doses, 21 days apart

Amid test data doubts, UK seeks temporary supply of AstraZeneca/Oxford vaccine
By Prasun Sonwalkar , edited by Vinod Janardhanan | Hindustan Times, London
UPDATED ON NOV 27, 2020 06:01 PM IST
The UK will be one of the first countries in the world to receive the vaccine, if authorised, with AstraZeneca expecting to have up to 4 million doses ready by the end of the year and 40mn by the end of March 2021.

Manufacturing error in AstraZeneca-Oxford Covid-19 vaccine: What went wrong
By hindustantimes.com | Edited by Srivatsan K C | Hindustan Times, New Delhi
UPDATED ON NOV 27, 2020 05:51 PM IST
Following Britain’s health secretary Matt Hancock, secretary of state for housing, communities and local government Rober Jenrick has also assured that the UK independent regulator would thoroughly assess the Covid-19 vaccine.

Britain asks regulator to assess Pfizer’s Covid-19 vaccine for suitability
By Reuters | Posted by Srivatsan K C | London
PUBLISHED ON NOV 21, 2020 01:23 AM IST
Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.3 million worldwide and crippled the global economy.

UK secures early access to 355 million doses of prospective Covid-19 vaccines
By Prasun Sonwalkar | Hindustan Times, London
PUBLISHED ON NOV 21, 2020 12:26 AM IST
Health secretary Matt Hancock said on Friday that recent news from the Pfizer and Oxford trials was promising

90-minute British DnaNudge Covid-19 test is accurate, Lancet study finds
By Reuters| Posted by Susmita Pakrasi | London
PUBLISHED ON SEP 18, 2020 02:07 PM IST
Faster testing could allow more people to return to work or permit testing on entry to hospital, thus slowing a second spike in coronavirus infections.

India, UK step up drive against illegal medicines smuggled to Britain, Europe
By Prasun Sonwalkar | Hindustan Times, London, London
UPDATED ON OCT 13, 2018 09:13 AM IST
India’s Directorate of Revenue Intelligence (DRI) recently seized 350,000 tablets of potent medicines, such as Diazepam, Tramadol and Zopiclone, destined for the UK, Europe and the US, Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) said on Thursday.